|
Delayed
Bombay S.E.
06:13:03 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 575.95 INR | +2.50% |
|
+5.68% | +31.35% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 20.84M | - | - | - | - | - |
| 1,019B | |||||
| 610B | - | ||||
| 470B | |||||
| 344B | |||||
| 336B |
Select your edition
All financial news and data tailored to specific country editions
